These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 5096513

  • 1. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia.
    Sterzel RB, Semar M, Lonergan ET, Treser G, Lange K.
    J Clin Invest; 1971 Nov; 50(11):2295-304. PubMed ID: 5096513
    [Abstract] [Full Text] [Related]

  • 2. Transketolase inhibition as a mechanism in uremic neuropathy.
    Lange K, Lonergan ET, Semar M, Sterzel RB.
    Trans Assoc Am Physicians; 1971 Nov; 84():172-81. PubMed ID: 5164301
    [No Abstract] [Full Text] [Related]

  • 3. The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity.
    Zhang F, Masania J, Anwar A, Xue M, Zehnder D, Kanji H, Rabbani N, Thornalley PJ.
    Kidney Int; 2016 Aug; 90(2):396-403. PubMed ID: 27198804
    [Abstract] [Full Text] [Related]

  • 4. Erythrocyte transketolase activity in uremia.
    Kuriyama M, Mizuma A, Yokomine R, Igata A, Otuji Y.
    Clin Chim Acta; 1980 Dec 08; 108(2):169-77. PubMed ID: 6256098
    [Abstract] [Full Text] [Related]

  • 5. Transketolase and myelin.
    Collins RC, Lonergan ET.
    N Engl J Med; 1971 Sep 23; 285(13):751-2. PubMed ID: 4398337
    [No Abstract] [Full Text] [Related]

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 23; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 7. Transketolase inhibition and uremic peripheral sensory neuropathy.
    Egan JD, Wells IC.
    J Neurol Sci; 1979 May 23; 41(3):379-95. PubMed ID: 220393
    [Abstract] [Full Text] [Related]

  • 8. Effect of hemodialysis on the inhibition of nervous tissue transketolase and on uremic neuropathy.
    Sterzel RB, Semar M, Lonergan ET, Lange K.
    Trans Am Soc Artif Intern Organs; 1971 May 23; 17():77-9. PubMed ID: 5158138
    [No Abstract] [Full Text] [Related]

  • 9. THE REGIONAL DISTRIBUTION OF TRANSKETOLASE IN THE NORMAL AND THE THIAMINE DEFICIENT NERVOUS SYSTEM.
    DREYFUS PM.
    J Neuropathol Exp Neurol; 1965 Jan 23; 24():119-29. PubMed ID: 14253567
    [No Abstract] [Full Text] [Related]

  • 10. Uremic neuropathy. Monitoring of transketolase activity inhibition in a child.
    McVicar M, Gauthier B, Goodman CT.
    Am J Dis Child; 1973 Feb 23; 125(2):263-5. PubMed ID: 4265477
    [No Abstract] [Full Text] [Related]

  • 11. Encephalopathy of thiamine deficieny: studies of intracerebral mechanisms.
    McCandless DW, Schenker S, Cook M.
    J Clin Invest; 1968 Oct 23; 47(10):2268-80. PubMed ID: 5676522
    [Abstract] [Full Text] [Related]

  • 12. Transketolase activity in uremia.
    Lonergan ET, Semar M, Lange K.
    Arch Intern Med; 1970 Nov 23; 126(5):851-4. PubMed ID: 5475709
    [No Abstract] [Full Text] [Related]

  • 13. Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia.
    Lonergan ET, Semar M, Sterzel RB, Treser G, Needle MA, Voyles L, Lange K.
    N Engl J Med; 1971 Jun 24; 284(25):1399-403. PubMed ID: 4325316
    [No Abstract] [Full Text] [Related]

  • 14. Metabolism of ribose-5-phosphate in hemolysates. III. Quantitative determination of sedoheptulose-7-phosphate and some properties of the transketolase of erythrocytes and blood serum.
    BRUNS FH, DUNWALD E, NOLTMANN E.
    Biochem Z; 1958 Jun 24; 330(6):497-508. PubMed ID: 13596392
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of the thiamine nutritional state of uremic patients by determination of erythrocyte transketolase activity].
    Rizzo SC, Varasi C.
    Minerva Nefrol; 1969 Jun 24; 16(4):301-5. PubMed ID: 5397050
    [No Abstract] [Full Text] [Related]

  • 16. [Non-uremic neuropathy in hemodialysis patients].
    Kondo H, Takeuchi M, Yatabe K, Mochizuki A, Iwata M.
    No To Shinkei; 1997 Aug 24; 49(8):737-43. PubMed ID: 9282368
    [Abstract] [Full Text] [Related]

  • 17. Erythrocyte transketolase activity in patients with diabetic and alcoholic neuropathies.
    Michalak S, Michałowska-Wender G, Adamcewicz G, Wender MB.
    Folia Neuropathol; 2013 Aug 24; 51(3):222-6. PubMed ID: 24114639
    [Abstract] [Full Text] [Related]

  • 18. Substrate inhibition of transketolase.
    Solovjeva ON, Kovina MV, Kochetov GA.
    Biochim Biophys Acta; 2016 Mar 24; 1864(3):280-282. PubMed ID: 26708478
    [Abstract] [Full Text] [Related]

  • 19. [Determination of transketolase activity in blood].
    Hoffmann I, Knapp A, Rietz K, Milner C.
    Clin Chim Acta; 1971 Jul 24; 33(2):415-21. PubMed ID: 5119318
    [No Abstract] [Full Text] [Related]

  • 20. A transketolase assembly defect in a Wernicke-Korsakoff syndrome patient.
    Wang JJ, Martin PR, Singleton CK.
    Alcohol Clin Exp Res; 1997 Jun 24; 21(4):576-80. PubMed ID: 9194907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.